Cascade Mono- and Di-Functionalization of Anticancer Diastereomeric Benzoxazole-Ansamycins toward the Development of Highly Potent Hsp90 Inhibitors of Decreased Toxicity in Normal Cells
Journal of Medicinal Chemistry · 12.11.2026 · 69 (21) · 25151-25180
DOI: 10.1021/acs.jmedchem.6c00563 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 18.10.2026. Verfasst von Aleksandra Leśniewska und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chemistry, Adam Mickiewicz University, Uniwersytetu Poznanskiego 8, 61-614Poznan, Poland. Hauptthemen laut MEDLINE: HSP90 Heat-Shock Proteins, Antineoplastic Agents, Benzoxazoles, Lactams, Macrocyclic. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Boehringer Ingelheim, Bayer, Pfizer.
Abstract (Originalsprache)
To reduce toxicity of geldanamycin (GDM), the domino transformation of its benzoquinone core into benzoxazole has been performed. Structural studies of ester-phenol and ester-ether benzoxazole-type ansamycins indicate that the former is present as (Sp)-diastereomer, whereas the latter is present as conformation-“locked” (Rp)-diastereomer, which is more favorable at binding to Hsp90. Several of the obtained benzoxazole ansamycins revealed high anticancer potency in SKBr-3, MCF-7, SKOV-3, and PC-3 lines with improved selectivity and lower affinity to glutathione, compared to GDM. The most potent derivative 6 reveals excellent anticancer activity (IC50 < 0.6 μM) with Hsp90 as the primary target [KD6-Hsp90 = 0.3 μM], limited off-target effects (kinases), and decreased toxicity (selectivity indices = 2.75−3.48) regarding GDM. Ester-ether type derivative 22 reveals good anticancer potency in SKOV-3 (IC50 = 0.62 μM) with reduced toxicity in human dermal fibroblast and human umbilical vein endothelial cells, improved selectivity (SISKOV-3 = 2.75), apoptotic index AISKOV-3 ∼8, and high chemical and in vivo stabilities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Chemistry, Adam Mickiewicz University, Uniwersytetu Poznanskiego 8, 61-614Poznan, Poland.
- Department of Physical Chemistry, Faculty of Chemistry, University of Lodz, Pomorska 163/165, Lodz90-236, Poland.
- Department of Pharmacology, Poznan University of Medical Sciences, Rokietnicka 5a, 60-806Poznań, Poland.
- Structural Genomics Consortium, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina27599, United States.
- Institute of Organic Chemistry, Polish Academy of Sciences, Kasprzaka 44/52, 01-224Warsaw, Poland.
- Lebenswissenschaftliche Fakultӓt, Institut fȕr Biologie, Biophysikalische Chemie, Humboldt-Universitӓt zu Berlin, Invalidenstraße 42, 10115Berlin, Germany.
ORCID-Profile: Aleksandra Leśniewska, Adam Buczkowski, Matthew J Binder, Alison D Axtman, Ewelina Smolarz, Krystian Pyta, Maria Gdaniec, Piotr Przybylski
Förderung
- Boehringer Ingelheim
- Bayer
- Pfizer
- Genome Canada
- Genentech
- Merck KGaA
- Eshelman Innovation
- Takeda Canada
Zitieren
APA
Leśniewska, A., Buczkowski, A., Ruszkowski, P., Binder, M. J., Axtman, A. D., Schilf, W., Smolarz, E., Pyta, K., Gdaniec, M., Bartl, F. J., & Przybylski, P. (2026). Cascade Mono- and Di-Functionalization of Anticancer Diastereomeric Benzoxazole-Ansamycins toward the Development of Highly Potent Hsp90 Inhibitors of Decreased Toxicity in Normal Cells. Journal of Medicinal Chemistry, 69(21), 25151-25180. https://doi.org/10.1021/acs.jmedchem.6c00563
Vancouver
Leśniewska A, Buczkowski A, Ruszkowski P, Binder MJ, Axtman AD, Schilf W, et al. Cascade Mono- and Di-Functionalization of Anticancer Diastereomeric Benzoxazole-Ansamycins toward the Development of Highly Potent Hsp90 Inhibitors of Decreased Toxicity in Normal Cells. Journal of Medicinal Chemistry. 2026;69(21):25151-25180. doi:10.1021/acs.jmedchem.6c00563
BibTeX
@article{Leniewska2026,
author = {Leśniewska, Aleksandra and Buczkowski, Adam and Ruszkowski, Piotr and Binder, Matthew J and Axtman, Alison D and Schilf, Wojciech and Smolarz, Ewelina and Pyta, Krystian and Gdaniec, Maria and Bartl, Franz J and Przybylski, Piotr},
title = {Cascade Mono- and Di-Functionalization of Anticancer Diastereomeric Benzoxazole-Ansamycins toward the Development of Highly Potent Hsp90 Inhibitors of Decreased Toxicity in Normal Cells},
journal = {Journal of Medicinal Chemistry},
year = {2026},
volume = {69},
number = {21},
pages = {25151--25180},
doi = {10.1021/acs.jmedchem.6c00563}
}
EUVIMED